Nonstimulants Drugs for Treatment Attention Deficit Hyperactivity Disorder.
The only currently existing, approved nonstimulant ADHD medication is atomoxetine (Strattera).
HOW DOES THIS DRUG WORK?
Strattera is a selective norepinephrine reuptake inhibitor, which essentially means it increases the activity of the brain chemical (or neurotransmitter) norepinephrine. More norepinehrine is thought to increase attention and control hyperactivity and impulsivity in ADHD.
WHAT ARE THE BENEFITS?
The effectiveness of Strattera in the treatment of ADHD was established in four studies of pediatric patients ages 6 to 18. Compared with placebo, Strattera proved to be superior with respect to reducing impulsiveness, hyperactivity, and inattention. The effectiveness of Strattera for long-term use (for more than nine weeks) in child and adolescent patients has not been thoroughly evaluated.
POTENTIAL SIDE EFFECTS
Common side effects are loss of appetite, drowsiness, headache, stomachache, nausea, vomiting, dizziness, dry mouth, diarrhea, constipation, difficulty sleeping, sexual dysfunction, agitation, irritability, and difficulty urinating.